Special notice: Important policy changes
May 2025Important Notices
Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.
- Varicose Veins – MP.066 is being retired and will be replaced by Varicose Veins – MP.PA.145.
- Genetic Testing – Hereditary and Multifactorial Diseases – MP.PA.118 is a new prior authorization policy.
- Laparoscopic Cholecystectomy, 18 Years Old and Older – MP.PA.146 is a new prior authorization policy.
- Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 is a new prior authorization policy.
- Cardiac Ablation Procedures, 18 Years Old and Older – MP.PA.148 is a new prior authorization policy.
Again, prior authorizations will be implemented in accordance with these policies beginning June 1.
If you have any questions or concerns about these policy changes, please contact your physician account executive or call Provider Services at 1-866-918-1595.
Thank you for the excellent care and support you provide to our members.
Recent Announcements
Important announcement – Telehealth submissions
As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.Sep. 2025Important Notices
October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update
Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.Sep. 2025Pharmacy Updates
Biosimilar Medication Formulary Updates
Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab productsSep. 2025Pharmacy Updates